| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 12.60 mm | 12.60 mm | 12.60 mm | 12.60 mm | 12.60 mm | 12.60 mm |
| Cash burn (monthly) | 5.95 mm | 1.10 mm | 10.02 mm | 8.05 mm | 6.85 mm | 6.19 mm |
| Cash used (since last report) | 32.02 mm | 5.90 mm | 53.91 mm | 43.30 mm | 36.88 mm | 33.28 mm |
| Cash remaining | -19.42 mm | 6.70 mm | -41.31 mm | -30.69 mm | -24.27 mm | -20.68 mm |
| Runway (months of cash) | -3.3 | 6.1 | -4.1 | -3.8 | -3.5 | -3.3 |
| 13F holders | Current |
|---|---|
| Total holders | 113 |
| Opened positions | 24 |
| Closed positions | 9 |
| Increased positions | 44 |
| Reduced positions | 17 |
| 13F shares | Current |
|---|---|
| Total value | 435.16 bn |
| Total shares | 45.36 mm |
| Total puts | 151.90 k |
| Total calls | 30.80 k |
| Total put/call ratio | 4.9 |
| Largest owners | Shares | Value |
|---|---|---|
| Soleus Private Equity Fund II | 3.93 mm | $62.36 mm |
| Biotechnology Value Fund L P | 3.47 mm | $52.34 mm |
| BVF | 3.47 mm | $51.68 bn |
| Soleus Capital Master Fund | 2.62 mm | $0.00 |
| Perceptive Advisors | 2.36 mm | $35.22 bn |
| Venrock Healthcare Capital Partners II | 2.17 mm | $0.00 |
| Baker Bros. Advisors | 1.87 mm | $27.96 bn |
| BlackRock | 1.81 mm | $26.99 bn |
| Vanguard | 1.63 mm | $24.27 bn |
| Eventide Asset Managment | 1.54 mm | $22.89 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 4 Mar 25 | Sullivan Brian F. | Common Stock | Gift | Acquire G | Yes | No | 0 | 36,845 | 0.00 | 802,742 |
| 4 Mar 25 | Sullivan Brian F. | Common Stock | Gift | Dispose G | Yes | No | 0 | 36,845 | 0.00 | 8,155 |
| 3 Mar 25 | Sullivan Brian F. | Common Stock | Gift | Acquire G | Yes | No | 0 | 45,000 | 0.00 | 45,000 |
| 3 Mar 25 | Sullivan Brian F. | Common Stock | Gift | Dispose G | No | No | 0 | 45,000 | 0.00 | 1,257,704 |
| 3 Mar 25 | Sullivan Brian F. | Common Stock | Gift | Acquire G | Yes | No | 0 | 39,670 | 0.00 | 948,042 |
| 3 Mar 25 | Sullivan Brian F. | Common Stock | Gift | Dispose G | No | No | 0 | 39,670 | 0.00 | 1,302,704 |
| 13 Feb 25 | Laing Lance G. | Stock Option Common Stock | Grant | Acquire A | No | No | 12.62 | 10,962 | 138.34 k | 10,962 |
| 2 Jan 25 | Vicky Hahne | Stock Option Common Stock | Grant | Acquire A | No | No | 13.13 | 11,328 | 148.74 k | 11,328 |
| 2 Dec 24 | Furcht Leo | Common Stock | Option exercise | Acquire M | No | No | 3.6 | 250 | 900.00 | 10,750 |
| 2 Dec 24 | Furcht Leo | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.6 | 250 | 900.00 | 0 |
